Blog

Viral Load Edition. "The solution to pollution is dilution." COVID risks explained. - Pain Care Labs

Written by paincare | Sep 23, 2020 5:26:35 PM
 

Filmed live at the Hive, Atlanta, Georgia, on September 23, 2020. Dr. Baxter discusses COVID viral load and what you can do to exercise a measure of control over the viral load. Our old friend nasal irrigation is on the menu today – Dr. Baxter still recommends it, especially when you’ve been around people you cannot “contact trace.”

 

Dr. Baxter covers a lot of nasal ground today! Risk factors covered: old, male, Black, Latinx, dense living, hypertension, obesity, diabetes. Living in Southeast Asia (where masks are common) means lower viral load, less risk…and they also do nasal irrigation as a common hygiene practice. These risk factors explain how nasal ACE2 receptors behave.

 

More than you ever wanted to know about ACE2 receptors. The “downregulation” of the expression of ACE2 receptors may be a key to reducing the spread of COVID. Decrease viral load by wearing a face covering. #WearAMask Try nasal irrigation when you have not been able to control your environment. Dr. Baxter covers the many studies underway to decrease the viral load.

 

Consider finding a pulse oximeter to have at home if you’re high risk. A reminder that recommended treatments and interventions depend on timing – where are you in the disease progression? Preventive, mild symptoms/outpatient/at-home, inpatient, and o2-requiring phases. Different phases respond to different treatments.

 

Buzzy and VibraCool are FDA registered 510(k) cleared to control pain associated with injections, venipuncture, IV starts, cosmetic injections and the temporary relief of minor injuries (muscle or tendon aches, splinters and bee stings). Also intended to treat myofascial pain caused by trigger points, restricted motion and muscle tension.

 

Dr. Amy Baxter, MD, bio & more pain relief options here: https://paincarelabs.com/resources/power-over-pain/

 

Dr. Amy Baxter directs innovation, invention, and strategy for Pain Care Labs. Accomplishments include international thought leadership on pain management and acute opioid reduction, multiple NIH SBIR Fast-Tracks, eight issued patents, multiple first author textbook chapters and journal publications, and successful 510K FDA clearances. After graduating from Yale University and Emory Medical School, as a double-boarded pediatric emergency physician, Dr. Baxter founded PEMA Emergency Research, created and validated the BARF pediatric nausea scale cited in fifty studies, and founded Pain Care Labs. Recognition includes Forbes Ten Healthcare Disruptors, Inc. Top Women in Tech to Watch, Top 10 Innovative and Disruptive Women in Healthcare, a Wall Street Journal “Idea Person”, and the Most Innovative CEO of 2014 from Georgia Bio. National and international lecturing highlights include MakerFaire, AARP, and TEDMED. On Homeolux Board of Directors. Also known for turning down Mr. Wonderful on Shark Tank.